Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Mathematical Biosciences|March 28, 2002
Non-linear dynamics models characterizing long-term virological data from AIDS clinical trialsDavide Verotta, Franziska SchaedeliJournal of Pharmacokinetics and Pharmacodynamics|June 22, 2014
Methods to detect non-compliance and reduce its impact on population PK parameter estimatesLeonid Gibiansky, Ekaterina Gibiansky, Valerie Cosson, et al.Journal of Pharmacokinetics and Pharmacodynamics|August 27, 2002
Influence of arterial vs. venous sampling site on nicotine tolerance model selection and parameter estimationFranziska Schaedeli, Maria Pitsiu, Neal L Benowitz, et al.Kidney International|June 18, 2004
The willingness of patients to accept an additional mortality risk in order to improve renal graft survivalVincenzo Girardi, Franziska Schaedeli, Hans-Peter Marti, et al.CPT: Pharmacometrics & Systems Pharmacology|August 19, 2024
Simulation-based evaluation of the Pharmpy Automatic Model Development tool for population pharmacokinetic modeling in early clinical drug developmentZrinka Duvnjak, Franziska Schaedeli Stark, Valérie Cosson, et al.Journal of Pharmacokinetics and Pharmacodynamics|July 24, 2025
A semi-mechanistic population pharmacokinetic-pharmacodynamic model to assess downstream drug-target effects on erythropoiesisS Viktor Rognås, Franziska Schaedeli Stark, Maddalena Marchesi, et al.Clinical and Translational Science|June 8, 2018
Population Pharmacokinetic and Exposure-dizziness Modeling for a Metabotropic Glutamate Receptor Subtype 5 Negative Allosteric Modulator in Major Depressive Disorder PatientsValérie Cosson, Franziska Schaedeli-Stark, Mona Arab-Alameddine, et al.Journal of Pharmacokinetics and Pharmacodynamics|February 3, 2024
A population pharmacokinetics model of balovaptan to support dose selection in adult and pediatric populationsFranziska Schaedeli Stark, Clarisse Chavanne, Michael Derks, et al.Cancer Chemotherapy and Pharmacology|March 19, 2017
An apparent clinical pharmacokinetic drug-drug interaction between bevacizumab and the anti-placental growth factor monoclonal antibody RO5323441 via a target-trapping mechanismKa Wang, Franziska Schaedeli Stark, Tilman Schlothauer, et al.Cancer Chemotherapy and Pharmacology|August 14, 2012
A population pharmacokinetic/pharmacodynamic model of thrombocytopenia characterizing the effect of trastuzumab emtansine (T-DM1) on platelet counts in patients with HER2-positive metastatic breast cancerBrendan C Bender, Franziska Schaedeli-Stark, Reinhold Koch, et al.Pageof 2